Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04014803 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Study acronym: ATTEMPT
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 30, 2025 to Jun 30, 2027
    • Study completion date: Dec 31, 2026 to Dec 31, 2028
    v7
  2. Re-verified, no change to tracked fieldsv6
  3. Primary completion date: Jun 30, 2024 to Jun 30, 2025
    • Study completion date: Dec 31, 2024 to Dec 31, 2026
    • Collaborators revised (19)
    v5
  4. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Jun 30, 2023 to Jun 30, 2024
    • Study sites: 0 to 2
    • Study completion date: Dec 31, 2023 to Dec 31, 2024
    • Start date changed from estimate of Nov 1, 2019 to Jan 13, 2020
  5. Start date: Aug 15, 2019 to Nov 1, 2019v3
  6. Start date: Jul 8, 2019 to Aug 15, 2019
    • Eligibility criteria expanded, about 33 words
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a prospective, open label, two-arm, randomized multicenter trial to evaluate the efficacy and safety of aspirin plus prasugrel as compared with aspirin plus clopidogrel in patients undergoing elective percutaneous coronary intervention with drug eluting stents for complex coronary lesions.
Trial Details
NCT Number NCT04014803
Lead Sponsor Samsung Medical Center
Collaborators: Inje University Ilsan Paik Hospital, Seoul St. Mary's Hospital, Mediplex Sejong Hospital, Chonnam National University Hospital, Sejong General Hospital, Wonkwang University Hospital, Gachon University Gil Medical Center, Keimyung University Dongsan Medical Center, Chungbuk National University Hospital, Yeungnam University Hospital, Chungnam National University Hospital, Wonju Severance Christian Hospital, Konkuk University Chungju Hospital, Chung-Ang University Hospital, Dankook University, Incheon St.Mary's Hospital, Gyeongsang National University Hospital, Soonchunhyang University Hospital, Ewha Womans University Seoul Hospital
Conditions
(from sponsor)		 Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 3,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov